Julie Gerberding

Julie Louise Gerberding (born August 22, 1955) is an American infectious disease expert and was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). She is currently the executive vice president for strategic communications, global public policy & population health and the chief patent officer at Merck.[1]

Dr.

Julie Louise Gerberding

MD, MPH
Born (1955-08-22) August 22, 1955
Estelline, South Dakota, U.S.
NationalityAmerican
EducationCase Western Reserve University (BA, MD)
University of California, Berkeley (MPH)
OccupationExecutive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health, Merck & Co., Inc.
Known forDirector of the Centers for Disease Control and Prevention under George W. Bush
Medical career
InstitutionsSan Francisco General Hospital
University of California, San Francisco
Emory University
United States Centers for Disease Control and Prevention
Merck & Co.
Sub-specialtiesEpidemiology
HIV
Infectious Disease

Gerberding became a recognized national figure during the 2001 anthrax attacks in the United States. As the Acting Deputy Director of National Center for Infectious Diseases, Gerberding was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath.[2]

Education and early career

Gerberding grew up in Estelline, South Dakota[3] and attended Brookings High School[4] and Case Western Reserve University, where she earned an undergraduate degree in biology in 1977 and an M.D. in 1981.[5] She completed her internship and was the chief medical resident at the University of California San Francisco, where she also completed a fellowship in Clinical Pharmacology and Infectious Diseases. Gerberding was an assistant professor at USCF from 1988-1995 and the director of the Epidemiology and Prevention Interventions Center at San Francisco General Hospital from 1990-1998.[4] She also earned an M.P.H. degree from the University of California Berkeley in 1990 [6] and was an Associate Clinical Professor of Medicine (Infectious Diseases) at Emory University.[7]

AIDS research

During her medical residency at San Francisco General Hospital, Gerberding treated some of the first hospitalized AIDS patients. She completed several studies on the risks of HIV to healthcare workers, created guidelines to prevent their infections, and established a treatment and research unit focused on HIV/AIDS cases among the urban poor.[8][9]

US CDC

In 1998, Gerberding was hired by the United States Centers for Disease Control and Prevention as the Director of the Division of Healthcare Quality Promotion. There, she "developed CDC's patient safety initiatives and other programs to prevent infections, antimicrobial resistance and medical errors in healthcare settings." [10]

In September 2001, she became the acting deputy director of the National Center for Infectious Diseases (NCID). During the 2001 anthrax attacks, Gerberding was part of a CDC team who regularly communicated with Congress, briefed the United States Health and Human Services senior staff, and communicated with the public about the crisis via daily press conferences.[9]

In April 2002, after the resignation of CDC Director Jeffrey Koplan, Gerberding became the acting principal deputy director of the CDC and deputy director of the NCID.

CDC director
Julie Gerberding speaking at the HealthierUS summit in April 2004.

In July 2002, Secretary of Health and Human Services Tommy Thompson named Gerberding as the director of the CDC and administrator for the Agency for Toxic Substances and Disease Registry (ATSDR).[6]

In May 2004, the CDC announced a significant restructuring to improve its preparedness for several types of threats, to promote health, and to better prevent disease, injury and disability.[11][12] The reorganization was controversial, and Gerberding received bipartisan criticism from individuals and occupational health & safety groups, mainly centered around the implications of the restructuring for the National Institute for Occupational Safety and Health.[13]

Other challenges of Gerberding's tenure as CDC Director included the American response to the global outbreak of Severe acute respiratory syndrome (SARS) and to several natural disasters, including Hurricane Katrina.

Gerberding resigned as CDC director effective on January 20, 2009, Barack Obama's inauguration day, to enable Obama's appointment for CDC director, Tom Frieden, to assume his position.[14][15]

Private sector

In December 2009, Gerberding became president of Merck's vaccine division.[16][17] In December 2014, the company announced her appointment as executive vice president for strategic communications, global public policy and population health. She remains in that position as of December 2020.[18]

Memberships

Honors
  • 2005 Time “100 Most Influential People in the World"
  • Forbes “100 Most Powerful Women in the World” 2005-2008,[23]
  • 2012 Distinguished Alumnus Award, Case Western Reserve University[5]
  • Honorary Doctor of Science, Mercer University[24]
  • Surgeon General's Medallion[23]
  • U.S. Department of Health and Human Services (DHHS) distinguished service award[1]
  • Healthcare Businesswomen Association's Woman of the Year 2018[25]

References
  1. "Julie L. Gerberding, M.D., M.P.H." Merck. Archived from the original on 29 December 2020. Retrieved 29 December 2020.
  2. Stobbe, Mike. "CDC director is leaving with a mixed legacy". The San Diego Union-Tribune. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  3. Crisler, Dan. "Former CDC Director Gerberding keeps in touch with Estelline roots". Aberdeen News. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  4. "How Did I Get Here? Julie Gerberding". Bloomberg.com. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  5. "Julie Gerberding, MD, (WRC '77, MED '81) 2012 Distinguished Alumnus Award". Case Western Reserve University. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  6. "Julie Gerberding, MD, MPH, Named CDC Director and ATSDR Administrator". CDC.gov. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  7. "The Mary Lynn Morgan Annual Lecture on Women and Health". Emory University. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  8. Roos, Robert. "Julie Gerberding named director of CDC". University of Minnesota Center for Infectious Disease Research and Policy. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  9. McKenna, M.A.J. "Infectious disease expert to lead CDC". UCLA Department of Epidemiology/School of Public Health. The Atlanta Journal-Constitution. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  10. "Julie L. Gerberding, MD, MPH Director, CDC; Administrator, ATSDR". The White House: President George W. Bush. Archived from the original on 29 December 2020. Retrieved 29 December 2020.
  11. "CDC Announces New Goals and Organizational Design". CDC. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  12. Roos, Robert. "Reorganization aims to boost CDC's preparedness impact". University of Minnesota Center for Infectious Disease Research and Policy. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  13. Weiss, Rick. "Change at CDC Draws Protest". The Washington Post. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  14. The Associated Press. "Director of Disease Control Centers Resigns". The New York Times. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  15. "CDC director resigns effective January 20". CNN Health. CNN. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  16. "Former CDC head lands vaccine job at Merck". Reuters. Archived from the original on 29 December 2020. Retrieved 29 December 2020.
  17. Silberner, Joanne. "Merck Hires Ex-CDC Chief Gerberding To Run Vaccines Unit". NPR. Archived from the original on 21 December 2019. Retrieved 30 December 2020.
  18. "Merck Announces Appointment of Dr. Julie Gerberding as Executive Vice President for Strategic Communications, Global Public Policy and Population Health". Business Wire. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  19. "Julie Louise Gerberding, M.D., M.P.H." National Academy of Medicine. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  20. "Your Colleagues: Members on the Move". Infectious Diseases Society of America. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  21. "Julie Louise Gerberding, MD, MPH". The American Society for Clinical Investigation. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  22. "Julie Gerberding". National Academy of Public Administration. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  23. "Julie Gerberding". Harvard T.H. Chan School of Public Health. Archived from the original on 29 December 2020. Retrieved 30 December 2020.
  24. Fullbright, Nancy. "GERBERDING RECEIVES HONORARY DOCTOR OF SCIENCE". Mercer University. Archived from the original on 30 December 2020. Retrieved 30 December 2020.
  25. "Dr. Julie Gerberding of Merck & Co., Inc., named 2018 Woman of the Year by the Healthcare Businesswomen's Association". Healthcare Businesswomen's Association. Archived from the original on 30 December 2020. Retrieved 30 December 2020.


Government offices
Preceded by
Jeffrey Koplan		 Director of the Centers for Disease Control and Prevention
2002 – 2009		 Succeeded by
Tom Frieden
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.